Novo Nordisk A/S ROCE Ratio 2011-2026 | NVO

Annual ROCE Ratio Novo Nordisk A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	477.98	580.82	83.47	88.55	96.66	97.09	79.52	68.3	66.94	49.82

All numbers in DKK currency

Indicator range from annual reports

Maximum	Minimum	Average
580.82	49.82	168.92

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-104.38	$ 3.85	3.22 %	$ 9.26 B	Australia
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	63.56	$ 326.56	-2.05 %	$ 42.8 B	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
AlloVir ALVR	-58.56	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	-164.32	$ 7.76	4.51 %	$ 76.7 M	USA
Allakos ALLK	-116.14	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	394.73	-	-	$ 8.42 M	USA
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-664.7	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	163.63	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	17.8	$ 21.48	-0.92 %	$ 1 B	USA
Burford Capital Limited BUR	14.24	$ 4.7	-0.74 %	$ 756 M	Britain
CymaBay Therapeutics CBAY	-34.79	-	-	$ 3.45 B	USA
Cabaletta Bio CABA	-153.72	$ 3.45	1.32 %	$ 347 M	USA
BioNTech SE BNTX	-4.81	$ 99.42	-0.05 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	-146.69	$ 3.1	-4.32 %	$ 5.1 M	Israel
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	545.12	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	72.06	$ 1.41	-9.12 %	$ 363 M	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	211.07	$ 4.16	-1.89 %	$ 445 M	USA
Arcutis Biotherapeutics ARQT	-6.45	$ 24.22	-1.46 %	$ 3.08 B	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	19.77	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	-151.88	$ 1.48	-0.67 %	$ 394 M	Britain
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	7.03	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	444.94	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-75.78	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	156.13	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	-54.51	$ 33.53	-1.0 %	$ 2.23 B	USA
bluebird bio BLUE	-125.56	-	-	$ 546 M	USA
CNS Pharmaceuticals CNSP	-353.49	$ 2.66	-3.34 %	$ 1.18 M	USA
AstraZeneca PLC AZN	11.12	-	-	$ 96.9 B	Britain